Personalis Inc. Watch

from 10-Q 3 pages Amendment No. 2 to the Commercialization and Reference Laboratory Agreement

from 8-K 2 pages Amendment No. 1 to the Commercialization and Reference Laboratory Agreement

from 8-K 19 pages In Accordance With Item 601(b)(10)(iv) of Regulation S-K, Information Indicated With “[***]” Has Been Redacted Because It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential. Settlement and License Agreement

from 10-Q 4 pages Personalis, Inc. Amended and Restated Non-Employee Director Compensation Policy Adopted by the Board of Directors: May 23, 2019 Last Amended by the Board of Directors: February 27, 2024

from 10-K 12 pages Personalis, Inc. Second Amended and Restated Executive Severance Agreement

from 10-K 12 pages Personalis, Inc. Third Amended and Restated Executive Severance Agreement

from 10-K 12 pages Personalis, Inc. Third Amended and Restated Executive Severance Agreement

from 10-K 10 pages Personalis, Inc. Second Amended and Restated Executive Severance Agreement

from 10-K 9 pages Personalis, Inc. Stock Option Grant Notice

from 10-K 9 pages Personalis, Inc. Restricted Stock Unit Grant Notice

from 10-K 20 pages Personalis, Inc. 2020 Inducement Plan Adopted by the Compensation Committee of the Board of Directors: May 4, 2020 Amended by the Compensation Committee of the Board of Directors: April 25, 2023

from 8-K 34 pages Commercialization and Reference Laboratory Agreement

from 10-Q 4 pages Personalis, Inc. Amended and Restated Non-Employee Director Compensation Policy Adopted by the Board of Directors: May 23, 2019 Last Amended by the Board of Directors: March 2, 2023

from 8-K 11 pages Personalis, Inc. Second Amended and Restated Executive Severance Agreement

from 8-K 9 pages Personalis, Inc. First Amended and Restated Executive Severance Agreement

from 8-K 11 pages Personalis, Inc. Second Amended and Restated Executive Severance Agreement

from 8-K 3 pages This First Amended and Restated Employment Terms Letter Agreement (“Agreement”) Between Personalis, Inc. (“Personalis” or “Company”) and You Supersedes in Its Entirety and Restates That Certain Employment Terms Letter Agreement Between You and Personalis Dated June 2, 2019 (The “Prior Agreement”). I Am Pleased to Offer You Continuing Full-Time Employment on the Following Terms. Upon Your Acceptance, These Terms Will Become Effective Immediately. Position Description Your Positions With Personalis Are Executive Vice President, Research & Development, and Chief Medical Officer, Reporting Directly to the Company’s Chief Executive Officer. You Will Work at the Company’s Corporate Headquarters, and Your Duties Will Require Business Travel. You Will Be Expected to Perform the Customary Duties of Your Position, Duties Specified in the Bylaws of the Company, and as May Be Required by the Company’s Board of Directors (The “Board”)

from 8-K 3 pages March 7, 2023 Christopher Hall San Francisco, Ca 94115 Chrishall1968@gmail.com Re: First Amended and Restated Offer Letter Agreement Dear Chris,

from 8-K 3 pages This First Amended and Restated Employment Terms Letter Agreement (“Agreement”) Between Personalis, Inc. (“Personalis” or “Company”) and You Supersedes in Its Entirety and Restates That Certain Employment Terms Letter Agreement Between You and Personalis Dated June 2, 2019 (The “Prior Agreement”). I Am Pleased to Offer You Continuing Full-Time Employment on the Following Terms. Upon Your Acceptance, These Terms Will Become Effective Immediately. Position Description

from 10-K 3 pages Amendment No. 3 to Lease